Sign in

CIK 0001505497

  • Non-accelerated filer
  • Smaller reporting company

BioRestorative Therapies, Inc.

Sign in to watch
Ticker
BRTX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
301341024
Phone
+1 631-760-8100
Business address
40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
Former names
Stem Cell Assurance, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy 10% owner bought 160,000 shares at an average $1.29 ($206,023)
  6. 4 Open-market buy 10% owner bought 120,000 shares at an average $1.35 ($162,255)
  7. 4 Open-market sale 10% owner sold 250 shares at $1.88 ($469)
  8. 4 Open-market sale 10% owner sold 278 shares at $1.89 ($525)
  9. 4 Open-market buy 10% owner bought 20,000 shares at an average $1.60 ($32,000)
  10. 4 Open-market buy President, CEO, COB bought 2,200 shares at $1.70 ($3,740)
  11. 4 Open-market buy 10% owner bought 2,500 shares at an average $2.07 ($5,165)
  12. 4 Open-market buy President, CEO, COB bought 800 shares at $1.53 ($1,226)
  13. 4 Open-market buy President, CEO, COB bought 2,887 shares at $1.96 ($5,659)
  14. 4 Open-market buy VP of Research and Development bought 4,954 shares at $2.22 ($10,998)
  15. 4 Open-market buy 10% owner bought 1,000 shares at $2.80 ($2,800)
  16. 4 Open-market buy President, CEO, COB bought 4,200 shares at $2.44 ($10,248)
  17. 4 Open-market buy VP of Research and Development bought 747 shares at $3.56 ($2,659)
  18. 4 Shares withheld for taxes VP of Research and Development gave up 6,729 shares (to pay taxes)
  19. 4 Shares withheld for taxes President, CEO, COB gave up 6,729 shares (to pay taxes)
  20. 4 Open-market buy 10% owner bought 6,200 shares at an average $2.86 ($17,705)

Page 2 of 15 · 291 filings